Therma Bright Inc. develops and sells rapid COVID testing products and medical devices for pain management and circulation improvement. The company faces significant financial challenges, evidenced by a gross margin of -46.0% and an alarming EBITDA margin of -5292.8%, indicating severe operational inefficiencies. Additionally, a current ratio of 0.11 and a quick ratio of 0.04 suggest liquidity issues that could hinder short-term obligations. While the healthcare sector offers growth potential, the company's financial health raises concerns about its sustainability and ability to capitalize on market opportunities.
Loading financial metrics...
Company has $1K in cash but burned $37K last quarter. At this burn rate, only 0.0 quarters of runway remain without additional financing.
Company posted a loss of $-4.3M over the last year, representing 5410.4% of revenue.
Debt of $40K is 27.3x the company's cash position of $1K.
Exceptional revenue growth of 207.9% YoY demonstrates strong market demand and competitive positioning.
Gross margin expanded by 10.2 percentage points, indicating improved pricing power or cost efficiency.
Operating margin expanded by 2431.0pp, demonstrating strong operational leverage.
Both gross margin (+10.2pp) and operating margin (+2431.0pp) are expanding simultaneously, indicating the company is scaling profitably.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical - Devices companies of a similar size
Based on 2025-FY (July 31, 2025)